[1] |
LUO Rong , HU Peian , XIE Tiansong , ZHANG Zehua , ZHOU Liangping , ZHOU Zhengrong , CHEN Lei .
The correlation of imaging, clinical features and pathology of myxoid fibrosarcoma
[J]. China Oncology, 2021, 31(8): 734-739.
|
[2] |
HU Guannan , CHEN Lei , ZHOU Liangping , ZHOU Zhengrong .
A case report of pulmonary malignant melanoma complicated with lung adenocarcinoma and literature review
[J]. China Oncology, 2021, 31(7): 647-650.
|
[3] |
DONG Shijie, HU Xiaoxin, WANG Wei, YANG Meng, YUE Lei, TONG Tong, GU Yajia.
Prediction of lymph node metastasis of cervical cancer based on multi-sequence MRI and multi-system imaging omics model
[J]. China Oncology, 2021, 31(6): 460-467.
|
[4] |
HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang .
Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer
[J]. China Oncology, 2021, 31(3): 221-226.
|
[5] |
CHEN Yang , LIU Wei , LI Ruimin , WANG Qifeng , SHEN Xigang , TANG Wei .
Radiogenomics: association between BI-RADS mammographic imaging features and the 21-gene recurrence score
[J]. China Oncology, 2020, 30(7): 505-511.
|
[6] |
SHI Zhiqiang , QIU Pengfei , LIU Yanbing , ZHAO Tong , SUN Xiao , CHEN Peng , WANG Chunjian , ZHANG Zhaopeng , CONG Binbin , WANG Yongsheng .
Selective elimination of axillary surgery staging after neoadjuvant chemotherapy for HER2 positive and triple-negative breast cancer
[J]. China Oncology, 2020, 30(3): 186-191.
|
[7] |
SUN Ruihong,WANG Xiang,SHEN Lijuan,MENG Fanhua,YIN Huabin .
Intravoxel incoherent motion parameters of breast cancer at MRI: effect of region of interest on parameter measurement consistency
[J]. China Oncology, 2019, 29(9): 700-708.
|
[8] |
SHI Wei, YU Xiaoli.
Stereotactic body radiation therapy in spinal oligometastases of breast cancer
[J]. China Oncology, 2019, 29(9): 736-745.
|
[9] |
ZHENG Weizhen, SUN Jujie, LIU Yanbing, QIU Pengfei, BI Zhao, ZHAO Tong, WANG Yongsheng.
Validation and modification study of axillary node pathologic complete response predictive model after neoadjuvant chemotherapy for breast cancer
[J]. China Oncology, 2019, 29(6): 445-451.
|
[10] |
WANG Minhong, ZHOU Lixiang, FENG Zhan.
Value of conventional MRI texture analysis in differential diagnosis of glioblastomas and primary central nervous system lymphoma
[J]. China Oncology, 2019, 29(4): 284-288.
|
[11] |
GU Bingxin, SUN Yuyun, YANG Zhongyi, LUO Jianmin, ZHANG Jianping, ZHANG Yingjian.
A dual-modality SPECT/MR probe of 99mTc-Transferrin-DTPA-Gd for the detection of tumor transferrin receptor expression in vivo
[J]. China Oncology, 2019, 29(2): 119-124.
|
[12] |
BI Zhao, LIU Jingjing, CHEN Peng, LIU Yanbing, ZHAO Tong, SUN Xiao, QIU Pengfei, WANG Yongsheng.
Internal mammary sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy
[J]. China Oncology, 2019, 29(2): 131-135.
|
[13] |
LIU Mengjun, LI Yuzhi, WANG Lihua, CHANG Mengran.
Clinical significance of squamous cell carcinoma antigen combined with magnetic resonance imaging in diagnosing pelvic lymph node metastasis of early cervical cancer
[J]. China Oncology, 2019, 29(2): 136-141.
|
[14] |
SUN Jiajun, LU Renquan, ZHENG Hui, et al.
The value of serum HER2-ECD level in neoadjuvant chemotherapy for breast cancer
[J]. China Oncology, 2019, 29(1): 32-36.
|
[15] |
SHI Zhiqiang, QIU Pengfei, CONG Binbin, et al.
Progress in selective elimination of breast surgery after neoadjuvant chemotherapy for breast cancer
[J]. China Oncology, 2018, 28(8): 609-613.
|